311 related articles for article (PubMed ID: 2811561)
1. Rhabdomyosarcoma of the ear and temporal bone.
Wiatrak BJ; Pensak ML
Laryngoscope; 1989 Nov; 99(11):1188-92. PubMed ID: 2811561
[TBL] [Abstract][Full Text] [Related]
2. [The outcome of treatments for carcinoma of the external auditory canal].
Schmerber S; Righini Ch; Soriano E; Delalande C; Dumas G; Reyt E; Lavieille JP
Rev Laryngol Otol Rhinol (Bord); 2005; 126(3):165-70. PubMed ID: 16366384
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyosarcoma of the ear-mastoid.
Deutsch M; Felder H
Laryngoscope; 1974 Apr; 84(4):586-92. PubMed ID: 4821517
[No Abstract] [Full Text] [Related]
5. Embryonal rhabdomyosarcoma of the temporal bone.
Viswanatha B
Ear Nose Throat J; 2007 Apr; 86(4):218, 220-2. PubMed ID: 17500393
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
[TBL] [Abstract][Full Text] [Related]
7. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
8. Genital rhabdomyosarcoma: current management and review of the literature.
Bell J; Averette H; Davis J; Toledano S
Obstet Gynecol Surv; 1986 May; 41(5):257-63. PubMed ID: 3517719
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
[TBL] [Abstract][Full Text] [Related]
10. [Pediatric rhabdomyosarcoma of the infratemporal fossa].
Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B
Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115
[TBL] [Abstract][Full Text] [Related]
11. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
[TBL] [Abstract][Full Text] [Related]
12. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
13. Rhabdomyosarcoma of the middle ear and mastoid in children.
Said H; Phang KS; Razi A; Khuzaiyah R; Patawari PH; Esa R
J Laryngol Otol; 1988 Jul; 102(7):614-9. PubMed ID: 3411216
[TBL] [Abstract][Full Text] [Related]
14. Embryonal rhabdomyosarcoma of the head and neck in children.
Sessions DG; Ragab AH; Vietti TJ; Biller HF; Ogura JH
Laryngoscope; 1973 Jun; 83(6):890-7. PubMed ID: 4351166
[No Abstract] [Full Text] [Related]
15. Combined therapy for middle ear rhabdomyosarcoma.
Cunningham D; Kung FH
Am J Dis Child; 1972 Sep; 124(3):401-2. PubMed ID: 5056879
[No Abstract] [Full Text] [Related]
16. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Spunt SL; Smith LM; Ruymann FB; Qualman SJ; Donaldson SS; Rodeberg DA; Anderson JR; Crist WM; Link MP
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6072-9. PubMed ID: 15447992
[TBL] [Abstract][Full Text] [Related]
17. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
18. [Rhabdomyosarcoma].
Hosoi H; Tsuchiya K; Sugimoto T
Gan To Kagaku Ryoho; 2007 Feb; 34(2):181-6. PubMed ID: 17301524
[TBL] [Abstract][Full Text] [Related]
19. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.
Arndt CA; Hawkins DS; Meyer WH; Sencer SF; Neglia JP; Anderson JR
Pediatr Blood Cancer; 2008 Jan; 50(1):33-6. PubMed ID: 17091486
[TBL] [Abstract][Full Text] [Related]
20. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?
Schuck A; Mattke AC; Schmidt B; Kunz DS; Harms D; Knietig R; Treuner J; Koscielniak E
J Clin Oncol; 2004 Jan; 22(1):143-9. PubMed ID: 14701776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
